Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Common baldness is a hereditary condition that can be treated with medications or surgery to prevent progression and improve self-esteem.

New understanding and treatments for hair loss are improving, but more research is needed.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

More research is needed to find effective treatments for Female Pattern Hair Loss.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Compound 4 is a promising treatment for hair loss with low toxicity.

Combination therapies are more effective for treating androgenetic alopecia than single treatments.

A woman successfully sued for not being told about a medication's side effects, emphasizing doctors' duty to inform patients.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Low iron and L-lysine levels can cause hair loss in women, and increasing these nutrients can reduce hair shedding.

Cortisone may help hair regrow by altering the local environment, with regrowth starting 3-4 weeks after treatment, but its use is not widely recommended.

The normal human prostate does not significantly affect blood DHT levels.

NIPT can help detect potential maternal cancer, and GIPXplore can identify immune diseases in pregnancies.

Healthcare providers should know how to manage facial hair issues in women due to their social impact.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Helicobacter pylori infection is common in Southern Iraq gastritis patients, affecting 64.1%.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Extracellular vesicles may effectively treat hair loss with minimal side effects.

Fetal environments contain various chemicals that may disrupt hormones.